Verdezyne Sells One of Its Technologies to DuPont Industrial Biosciences

Verdezyne, an industrial biotechnology company based in Carlsbad, Calif., has sold its proprietary xylose isomerase technology to DuPont Industrial Biosciences for an undisclosed amount. Current investors in Verdezyne include BP Alternative Energy Ventures, DSM Venturing B.V., OVP Venture Partners and Monitor Ventures.

North AmericaUSBriefs